ACTRN12620001287921
Recruiting
未知
Assessment of DNA damage-repair capacity in systemic lupus erythematosus patients as a potential biomarker of response to cyclophosphamide.
niversity of Auckland0 sites17 target enrollmentNovember 27, 2020
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- niversity of Auckland
- Enrollment
- 17
- Status
- Recruiting
- Last Updated
- 5 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •\>18 years of age
- •Diagnosed with lupus nephritis
- •Able to give informed consent
- •Not currently receiving cyclophosphamide or other alkylating agent
Exclusion Criteria
- •Not able to provide a blood sample
- •Currently taking cyclophosphamide or other alkylating agent
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
A clinical trial to study the prediction of result of chemotherapy in Acute myeloid leukemia by evaluating in vitro DNA damage.CTRI/2010/091/000015Dr. KH Reeta,Assistant professorDepartment of PharmacologyAIIMS, New Delhi-11002930
Completed
Not Applicable
Evaluation of DNA damage in anesthesiologistsDNA damage of anesthesiologists.SP4.011.087.693.339RBR-4vrz2mDepartamento de Anestesiologia
Completed
Not Applicable
Embryo DNA Repair Capacity ProjectInfertilityNCT03953859Reproductive Medicine Associates of New Jersey6
Recruiting
Not Applicable
DNA damage response in tumours of patients with endometrial cancerEndometrial cancerNL-OMON23000ErasmusMC50
Recruiting
Not Applicable
Radiation-induced DNA repair mechanisms andchromosomal changesRadiation-induced DNA repair mechanisms and chromosomal changesDRKS00034426niversitätsklinikum Heidelberg120